The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins

It is known that cell culture density can modulate the drug resistance of acute myeloid leukemia (AML) cells. In this work, we studied the drug sensitivity of AML cells in high-density cell cultures (cell lines THP-1, HL-60, MV4-11, and U937). It was shown that the AML cells in high-density cell cul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2022-07, Vol.23 (14), p.7881
Hauptverfasser: Kobyakova, Margarita, Lomovskaya, Yana, Senotov, Anatoly, Lomovsky, Alexey, Minaychev, Vladislav, Fadeeva, Irina, Shtatnova, Daria, Krasnov, Kirill, Zvyagina, Alena, Odinokova, Irina, Akatov, Vladimir, Fadeev, Roman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 14
container_start_page 7881
container_title International journal of molecular sciences
container_volume 23
creator Kobyakova, Margarita
Lomovskaya, Yana
Senotov, Anatoly
Lomovsky, Alexey
Minaychev, Vladislav
Fadeeva, Irina
Shtatnova, Daria
Krasnov, Kirill
Zvyagina, Alena
Odinokova, Irina
Akatov, Vladimir
Fadeev, Roman
description It is known that cell culture density can modulate the drug resistance of acute myeloid leukemia (AML) cells. In this work, we studied the drug sensitivity of AML cells in high-density cell cultures (cell lines THP-1, HL-60, MV4-11, and U937). It was shown that the AML cells in high-density cell cultures in vitro were significantly more resistant to DNA-damaging drugs and recombinant ligand izTRAIL than those in low-density cell cultures. To elucidate the mechanism of the increased drug resistance of AML cells in high-density cell cultures, we studied the activation of Bcl-2, Hif-1alpha, and NF-kB proteins, as well as cytokine secretion, the inflammatory immunophenotype, and the transcriptome for THP-1 cells in the low-density and high-density cultures. The results indicated that the increase in the drug resistance of proliferating THP-1 cells in high-density cell cultures was associated with the accumulation of inflammatory cytokines in extracellular medium, and the formation of NF-kB-dependent inflammatory-like cell activation with the anti-apoptotic proteins Bcl-2 and Bcl-xl. The increased drug resistance of THP-1 cells in high-density cultures can be reduced by ABT-737, an inhibitor of Bcl-2 family proteins, and by inhibitors of NF-kB. The results suggest a mechanism for increasing the drug resistance of AML cells in the bone marrow and are of interest for developing a strategy to suppress this resistance.
doi_str_mv 10.3390/ijms23147881
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9324792</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2695294790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-3bd749c53f995a5a97f8f87c348fc050a81d48b620c745510e3073db12f8638b3</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiNERUvhxg-wxIUDLv7Ih31BCltgKy2iQss5cpzJ7mwTe7Gdov1n_DyybYVaTuMZP37fGWuy7A1nF1Jq9gF3YxSS55VS_Fl2xnMhKGNl9fzR-TR7GeOOMSFFoV9kp7JQqhKiPMv-rLdArpwNYCIQdCTN-WWYNuQHRIzJOAvE96S2UwLy7QCDx46sYLqBEQ1ZL68pJwsYhnh8vMTNll6Ci5gOd1WymIY0hdkikjpGb9Ek6MhvTNvZtR_MOJrkw4EOeAOzScJbk9A7YlxHapeQ1nu_Tz6hJZ_sQAW5Dj4BuvgqO-nNEOH1QzzPfn75vF4s6er716tFvaJWcp2obLsq17aQvdaFKYyuetWryspc9ZYVzCje5aotBbNVXhScgWSV7FouelVK1crz7OO97n5qR-gsuBTM0OwDjiYcGm-weXrjcNts_G2jpcgrLWaBdw8Cwf-aIKZmxGjnvzEO_BQbUepC6BllM_r2P3Tnp-Dm8Y5Uzlgu2VHw_T1lg48xQP-vGc6a40o0j1dC_gU3DamL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2694004302</pqid></control><display><type>article</type><title>The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kobyakova, Margarita ; Lomovskaya, Yana ; Senotov, Anatoly ; Lomovsky, Alexey ; Minaychev, Vladislav ; Fadeeva, Irina ; Shtatnova, Daria ; Krasnov, Kirill ; Zvyagina, Alena ; Odinokova, Irina ; Akatov, Vladimir ; Fadeev, Roman</creator><creatorcontrib>Kobyakova, Margarita ; Lomovskaya, Yana ; Senotov, Anatoly ; Lomovsky, Alexey ; Minaychev, Vladislav ; Fadeeva, Irina ; Shtatnova, Daria ; Krasnov, Kirill ; Zvyagina, Alena ; Odinokova, Irina ; Akatov, Vladimir ; Fadeev, Roman</creatorcontrib><description>It is known that cell culture density can modulate the drug resistance of acute myeloid leukemia (AML) cells. In this work, we studied the drug sensitivity of AML cells in high-density cell cultures (cell lines THP-1, HL-60, MV4-11, and U937). It was shown that the AML cells in high-density cell cultures in vitro were significantly more resistant to DNA-damaging drugs and recombinant ligand izTRAIL than those in low-density cell cultures. To elucidate the mechanism of the increased drug resistance of AML cells in high-density cell cultures, we studied the activation of Bcl-2, Hif-1alpha, and NF-kB proteins, as well as cytokine secretion, the inflammatory immunophenotype, and the transcriptome for THP-1 cells in the low-density and high-density cultures. The results indicated that the increase in the drug resistance of proliferating THP-1 cells in high-density cell cultures was associated with the accumulation of inflammatory cytokines in extracellular medium, and the formation of NF-kB-dependent inflammatory-like cell activation with the anti-apoptotic proteins Bcl-2 and Bcl-xl. The increased drug resistance of THP-1 cells in high-density cultures can be reduced by ABT-737, an inhibitor of Bcl-2 family proteins, and by inhibitors of NF-kB. The results suggest a mechanism for increasing the drug resistance of AML cells in the bone marrow and are of interest for developing a strategy to suppress this resistance.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23147881</identifier><identifier>PMID: 35887226</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Acute myeloid leukemia ; Apoptosis ; Bcl-2 protein ; Bcl-x protein ; Bone marrow ; Cell activation ; Cell culture ; Cell cycle ; Cell growth ; Chemotherapy ; Cytokines ; Cytotoxicity ; DNA damage ; Drug resistance ; Hypoxia ; Hypoxia-inducible factor 1a ; Inflammation ; Leukemia ; NF-κB protein ; Proteins ; Reagents ; Transcriptomes</subject><ispartof>International journal of molecular sciences, 2022-07, Vol.23 (14), p.7881</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-3bd749c53f995a5a97f8f87c348fc050a81d48b620c745510e3073db12f8638b3</citedby><cites>FETCH-LOGICAL-c319t-3bd749c53f995a5a97f8f87c348fc050a81d48b620c745510e3073db12f8638b3</cites><orcidid>0000-0002-1709-9970 ; 0000-0001-8764-691X ; 0000-0002-2044-8510 ; 0000-0002-6331-0191 ; 0000-0002-2655-7670</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324792/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324792/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids></links><search><creatorcontrib>Kobyakova, Margarita</creatorcontrib><creatorcontrib>Lomovskaya, Yana</creatorcontrib><creatorcontrib>Senotov, Anatoly</creatorcontrib><creatorcontrib>Lomovsky, Alexey</creatorcontrib><creatorcontrib>Minaychev, Vladislav</creatorcontrib><creatorcontrib>Fadeeva, Irina</creatorcontrib><creatorcontrib>Shtatnova, Daria</creatorcontrib><creatorcontrib>Krasnov, Kirill</creatorcontrib><creatorcontrib>Zvyagina, Alena</creatorcontrib><creatorcontrib>Odinokova, Irina</creatorcontrib><creatorcontrib>Akatov, Vladimir</creatorcontrib><creatorcontrib>Fadeev, Roman</creatorcontrib><title>The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins</title><title>International journal of molecular sciences</title><description>It is known that cell culture density can modulate the drug resistance of acute myeloid leukemia (AML) cells. In this work, we studied the drug sensitivity of AML cells in high-density cell cultures (cell lines THP-1, HL-60, MV4-11, and U937). It was shown that the AML cells in high-density cell cultures in vitro were significantly more resistant to DNA-damaging drugs and recombinant ligand izTRAIL than those in low-density cell cultures. To elucidate the mechanism of the increased drug resistance of AML cells in high-density cell cultures, we studied the activation of Bcl-2, Hif-1alpha, and NF-kB proteins, as well as cytokine secretion, the inflammatory immunophenotype, and the transcriptome for THP-1 cells in the low-density and high-density cultures. The results indicated that the increase in the drug resistance of proliferating THP-1 cells in high-density cell cultures was associated with the accumulation of inflammatory cytokines in extracellular medium, and the formation of NF-kB-dependent inflammatory-like cell activation with the anti-apoptotic proteins Bcl-2 and Bcl-xl. The increased drug resistance of THP-1 cells in high-density cultures can be reduced by ABT-737, an inhibitor of Bcl-2 family proteins, and by inhibitors of NF-kB. The results suggest a mechanism for increasing the drug resistance of AML cells in the bone marrow and are of interest for developing a strategy to suppress this resistance.</description><subject>Acute myeloid leukemia</subject><subject>Apoptosis</subject><subject>Bcl-2 protein</subject><subject>Bcl-x protein</subject><subject>Bone marrow</subject><subject>Cell activation</subject><subject>Cell culture</subject><subject>Cell cycle</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Cytokines</subject><subject>Cytotoxicity</subject><subject>DNA damage</subject><subject>Drug resistance</subject><subject>Hypoxia</subject><subject>Hypoxia-inducible factor 1a</subject><subject>Inflammation</subject><subject>Leukemia</subject><subject>NF-κB protein</subject><subject>Proteins</subject><subject>Reagents</subject><subject>Transcriptomes</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkk1v1DAQhiNERUvhxg-wxIUDLv7Ih31BCltgKy2iQss5cpzJ7mwTe7Gdov1n_DyybYVaTuMZP37fGWuy7A1nF1Jq9gF3YxSS55VS_Fl2xnMhKGNl9fzR-TR7GeOOMSFFoV9kp7JQqhKiPMv-rLdArpwNYCIQdCTN-WWYNuQHRIzJOAvE96S2UwLy7QCDx46sYLqBEQ1ZL68pJwsYhnh8vMTNll6Ci5gOd1WymIY0hdkikjpGb9Ek6MhvTNvZtR_MOJrkw4EOeAOzScJbk9A7YlxHapeQ1nu_Tz6hJZ_sQAW5Dj4BuvgqO-nNEOH1QzzPfn75vF4s6er716tFvaJWcp2obLsq17aQvdaFKYyuetWryspc9ZYVzCje5aotBbNVXhScgWSV7FouelVK1crz7OO97n5qR-gsuBTM0OwDjiYcGm-weXrjcNts_G2jpcgrLWaBdw8Cwf-aIKZmxGjnvzEO_BQbUepC6BllM_r2P3Tnp-Dm8Y5Uzlgu2VHw_T1lg48xQP-vGc6a40o0j1dC_gU3DamL</recordid><startdate>20220717</startdate><enddate>20220717</enddate><creator>Kobyakova, Margarita</creator><creator>Lomovskaya, Yana</creator><creator>Senotov, Anatoly</creator><creator>Lomovsky, Alexey</creator><creator>Minaychev, Vladislav</creator><creator>Fadeeva, Irina</creator><creator>Shtatnova, Daria</creator><creator>Krasnov, Kirill</creator><creator>Zvyagina, Alena</creator><creator>Odinokova, Irina</creator><creator>Akatov, Vladimir</creator><creator>Fadeev, Roman</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1709-9970</orcidid><orcidid>https://orcid.org/0000-0001-8764-691X</orcidid><orcidid>https://orcid.org/0000-0002-2044-8510</orcidid><orcidid>https://orcid.org/0000-0002-6331-0191</orcidid><orcidid>https://orcid.org/0000-0002-2655-7670</orcidid></search><sort><creationdate>20220717</creationdate><title>The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins</title><author>Kobyakova, Margarita ; Lomovskaya, Yana ; Senotov, Anatoly ; Lomovsky, Alexey ; Minaychev, Vladislav ; Fadeeva, Irina ; Shtatnova, Daria ; Krasnov, Kirill ; Zvyagina, Alena ; Odinokova, Irina ; Akatov, Vladimir ; Fadeev, Roman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-3bd749c53f995a5a97f8f87c348fc050a81d48b620c745510e3073db12f8638b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acute myeloid leukemia</topic><topic>Apoptosis</topic><topic>Bcl-2 protein</topic><topic>Bcl-x protein</topic><topic>Bone marrow</topic><topic>Cell activation</topic><topic>Cell culture</topic><topic>Cell cycle</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Cytokines</topic><topic>Cytotoxicity</topic><topic>DNA damage</topic><topic>Drug resistance</topic><topic>Hypoxia</topic><topic>Hypoxia-inducible factor 1a</topic><topic>Inflammation</topic><topic>Leukemia</topic><topic>NF-κB protein</topic><topic>Proteins</topic><topic>Reagents</topic><topic>Transcriptomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kobyakova, Margarita</creatorcontrib><creatorcontrib>Lomovskaya, Yana</creatorcontrib><creatorcontrib>Senotov, Anatoly</creatorcontrib><creatorcontrib>Lomovsky, Alexey</creatorcontrib><creatorcontrib>Minaychev, Vladislav</creatorcontrib><creatorcontrib>Fadeeva, Irina</creatorcontrib><creatorcontrib>Shtatnova, Daria</creatorcontrib><creatorcontrib>Krasnov, Kirill</creatorcontrib><creatorcontrib>Zvyagina, Alena</creatorcontrib><creatorcontrib>Odinokova, Irina</creatorcontrib><creatorcontrib>Akatov, Vladimir</creatorcontrib><creatorcontrib>Fadeev, Roman</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kobyakova, Margarita</au><au>Lomovskaya, Yana</au><au>Senotov, Anatoly</au><au>Lomovsky, Alexey</au><au>Minaychev, Vladislav</au><au>Fadeeva, Irina</au><au>Shtatnova, Daria</au><au>Krasnov, Kirill</au><au>Zvyagina, Alena</au><au>Odinokova, Irina</au><au>Akatov, Vladimir</au><au>Fadeev, Roman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins</atitle><jtitle>International journal of molecular sciences</jtitle><date>2022-07-17</date><risdate>2022</risdate><volume>23</volume><issue>14</issue><spage>7881</spage><pages>7881-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>It is known that cell culture density can modulate the drug resistance of acute myeloid leukemia (AML) cells. In this work, we studied the drug sensitivity of AML cells in high-density cell cultures (cell lines THP-1, HL-60, MV4-11, and U937). It was shown that the AML cells in high-density cell cultures in vitro were significantly more resistant to DNA-damaging drugs and recombinant ligand izTRAIL than those in low-density cell cultures. To elucidate the mechanism of the increased drug resistance of AML cells in high-density cell cultures, we studied the activation of Bcl-2, Hif-1alpha, and NF-kB proteins, as well as cytokine secretion, the inflammatory immunophenotype, and the transcriptome for THP-1 cells in the low-density and high-density cultures. The results indicated that the increase in the drug resistance of proliferating THP-1 cells in high-density cell cultures was associated with the accumulation of inflammatory cytokines in extracellular medium, and the formation of NF-kB-dependent inflammatory-like cell activation with the anti-apoptotic proteins Bcl-2 and Bcl-xl. The increased drug resistance of THP-1 cells in high-density cultures can be reduced by ABT-737, an inhibitor of Bcl-2 family proteins, and by inhibitors of NF-kB. The results suggest a mechanism for increasing the drug resistance of AML cells in the bone marrow and are of interest for developing a strategy to suppress this resistance.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>35887226</pmid><doi>10.3390/ijms23147881</doi><orcidid>https://orcid.org/0000-0002-1709-9970</orcidid><orcidid>https://orcid.org/0000-0001-8764-691X</orcidid><orcidid>https://orcid.org/0000-0002-2044-8510</orcidid><orcidid>https://orcid.org/0000-0002-6331-0191</orcidid><orcidid>https://orcid.org/0000-0002-2655-7670</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2022-07, Vol.23 (14), p.7881
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9324792
source MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Acute myeloid leukemia
Apoptosis
Bcl-2 protein
Bcl-x protein
Bone marrow
Cell activation
Cell culture
Cell cycle
Cell growth
Chemotherapy
Cytokines
Cytotoxicity
DNA damage
Drug resistance
Hypoxia
Hypoxia-inducible factor 1a
Inflammation
Leukemia
NF-κB protein
Proteins
Reagents
Transcriptomes
title The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T04%3A59%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Increase%20in%20the%20Drug%20Resistance%20of%20Acute%20Myeloid%20Leukemia%20THP-1%20Cells%20in%20High-Density%20Cell%20Culture%20Is%20Associated%20with%20Inflammatory-like%20Activation%20and%20Anti-Apoptotic%20Bcl-2%20Proteins&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Kobyakova,%20Margarita&rft.date=2022-07-17&rft.volume=23&rft.issue=14&rft.spage=7881&rft.pages=7881-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23147881&rft_dat=%3Cproquest_pubme%3E2695294790%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2694004302&rft_id=info:pmid/35887226&rfr_iscdi=true